Pandemic influenza (H1N1) vaccines: Review [Pandemik i·nfluenza (H1N1) aşilari]

dc.contributor.authorFeyza K.O.Ç.
dc.contributor.authorAslan A.
dc.contributor.authorKurugöl Z.
dc.date.accessioned2019-10-26T22:08:07Z
dc.date.available2019-10-26T22:08:07Z
dc.date.issued2011
dc.departmentEge Üniversitesien_US
dc.description.abstractAfter started at March 2009 in Mexico, the pandemic influenza started to spread with rapidly in the world. World Health Organization (WHO) said that over 16000 people died from this infection. The Ministry of Health of Turkey announced 627 people died from pandemic influenza at 20 January 2010. H1N1 started to spread rapidly nearly pandemic, the vaccine research has been started and the vaccines developed. The pandemic influenza vaccines are non-adjuvanded, adjuvanded, and live attenuated vaccines. Since the application of pandemic influenza vaccine started swiftly, the community could not be informed sufficiently. Therefore, problems about application confronted. Squalene and thiomersal in adjuvanded vaccines and Guillain Barré syndrome (GBS) are the most discussed topics. Start of vaccination adverse effects and their activity is been observing and the studies are continuing, the vaccine several adverse effects have no difference of security profiles. Perspiration, erythema and pain on enjected area are the most seen side effects as predicted. Also these side effects healed without any treatment at short time. Fever, headache, fatigue, myalgia are reported as rarely side effects. These side effects healed without any treatment in 48 hours too. At this article, we purpose to give information about H1N1 vaccines which are using in Europe and USA. Copyright © 2011 by Türkiye Klinikleri.en_US
dc.identifier.endpage61en_US
dc.identifier.issn1300-0381
dc.identifier.issn1300-0381en_US
dc.identifier.issue1en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage52en_US
dc.identifier.urihttps://hdl.handle.net/11454/19286
dc.identifier.volume20en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.relation.ispartofTurkiye Klinikleri Pediatrien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdjuvantsen_US
dc.subjectH1N1 subtypeen_US
dc.subjectImmunologicen_US
dc.subjectInfluenza A virusen_US
dc.subjectInfluenza vaccinesen_US
dc.titlePandemic influenza (H1N1) vaccines: Review [Pandemik i·nfluenza (H1N1) aşilari]en_US
dc.typeReview Articleen_US

Dosyalar